首页|普拉克索联合多巴丝肼对帕金森病患者认知功能、氧化应激指标及Hcy的影响

普拉克索联合多巴丝肼对帕金森病患者认知功能、氧化应激指标及Hcy的影响

扫码查看
目的:分析普拉克索联合多巴丝肼对帕金森病患者认知功能、氧化应激指标及同型半胱氨酸(Hcy)的影响。方法:选取 2020 年 1 月—2022 年 10 月宿迁市第一人民医院收治的 92 例帕金森病患者。随机将其分为对照组和观察组,各46 例。对照组给予多巴丝肼治疗,观察组在对照组基础上给予普拉克索治疗。比较两组治疗前后认知功能、氧化应激指标、Hcy及临床疗效。结果:治疗后,两组简易智力状态检查量表(MMSE)评分均升高,观察组MMSE评分高于对照组,差异有统计学意义(P<0。05)。观察组总有效率高于对照组,差异有统计学意义(P<0。05)。治疗后,两组谷胱甘肽过氧化物酶(GSH-Px)和超氧化物歧化酶(SOD)水平均升高,观察组GSH-Px和SOD水平均高于对照组,差异有统计学意义(P<0。05)。治疗后,两组Hcy水平降低,观察组Hcy水平低于对照组,差异有统计学意义(P<0。05)。结论:普拉克索联合多巴丝肼可改善帕金森病患者认知功能,改善氧化应激反应,降低Hcy水平,具有较好的临床疗效。
Effects of Pramipexole Combined with Levodopa and Benserazide Hydrochloride on Cognitive Function,Oxidative Stress Indexes and Hcy in Patients with Parkinson Disease
Objective:To analyze the effects of Pramipexole combined with Levodopa and Benserazide Hydrochloride on cognitive function,oxidative stress indexes and Homocysteine(Hcy)in patients with Parkinson disease.Method:A total of 92 patients with Parkinson disease treated in the First People's Hospital of Suqian City from January 2020 to October 2022 were selected.They were randomly divided into control group and observation group,46 cases in each group.The control group was treated with Levodopa and Benserazide Hydrochloride,and the observation group was treated with Pramipexole on the basis of the control group.The cognitive function,oxidative stress indexes,Hcy before and after treatment and clinical efficacy of the two groups were compared.Result:After treatment,the mini-mental state examination scale(MMSE)scores of both groups were increased,and the MMSE score of the observation group was higher than that of the control group,the differences were statistically significant(P<0.05).The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of glutathione peroxidase(GSH-Px)and superoxide dismutase(SOD)in both groups were increased,and the levels of GSH-Px and SOD in observation group were higher than those in control group,the differences were statistically significant(P<0.05).After treatment,the Hcy level of the two groups decreased,and the Hcy level of the observation group was lower than that of the control group,the differences were statistically significant(P<0.05).Conclusion:Pramipexole combined with Levodopa and Benserazide Hydrochloride can improve cognitive function and oxidative stress response in patients with Parkinson disease,and reduce Hcy level,has good clinical efficacy.

PramipexoleLevodopa and Benserazide HydrochlorideCognitive functionParkinson diseaseOxidative stress

徐七、李丹、彭小妍、陈芳芳

展开 >

宿迁市第一人民医院 江苏 宿迁 223800

普拉克索 多巴丝肼 认知功能 帕金森病 氧化应激

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(3)
  • 21